• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器人辅助微创食管切除术(RAMIE)与传统微创食管切除术(MIE)治疗食管癌的比较:2017年至2020年全国住院患者样本分析

Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) vs. Conventional Minimally Invasive Esophagectomy (MIE) for Esophageal Cancer: A Nationwide Inpatient Sample Analysis from 2017 to 2020.

作者信息

Ruan Weizhong, Cai Yibin, Chen Weisheng

机构信息

Department of Thoracic Surgery, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University, Fuzhou, Fujian, China.

出版信息

Ann Thorac Cardiovasc Surg. 2025;31(1). doi: 10.5761/atcs.oa.25-00017.

DOI:10.5761/atcs.oa.25-00017
PMID:40414702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12104546/
Abstract

PURPOSE

This study compared the short-term outcomes after conventional minimally invasive esophagectomy (MIE) vs. robot-assisted minimally invasive esophagectomy (RAMIE)s by analyzing national data.

METHODS

Data were collected from adults aged ≥20 years who underwent MIE from 2017 to 2020, from the US Nationwide Inpatient Sample database. The outcomes included in-hospital mortality, unfavorable discharges, prolonged length of stays (LOS), total hospital charge, and various complications. Propensity score matching (PSM) was employed to balance the baseline characteristics between RAMIE and conventional MIE.

RESULTS

After PSM, 628 patients (representing 3140 patients in the US after weighting) were analyzed. After adjustment, multivariable analysis revealed no significant differences between RAMIE and traditional MIE in terms of in-hospital mortality (adjusted odd ratio [aOR] =1.45, 95% confidence interval [CI]: 0.46-4.61), unfavorable discharge (aOR = 0.76, 95%CI: 0.41-1.41), prolonged LOS (aOR = 0.87, 95%CI: 0.60-1.26), total hospital charge (aBeta = 12.23, 95%CI: -19.24 to 43.69), or complications (aOR = 1.05, 95%CI: 0.78-1.41). Stratified analysis indicated that, among obese patients, RAMIE was associated significantly with a higher risk of overall complications compared with MIE (aOR = 1.90, 95%CI: 1.11-3.25).

CONCLUSIONS

The study found no significant differences in unfavorable discharge and prolonged LOS between RAMIE and traditional MIE. Nevertheless, obese patients undergoing RAMIE experienced higher complications.

摘要

目的

本研究通过分析全国数据,比较传统微创食管切除术(MIE)与机器人辅助微创食管切除术(RAMIE)后的短期结局。

方法

数据收集自2017年至2020年在美国全国住院患者样本数据库中接受MIE的≥20岁成年人。结局指标包括住院死亡率、不良出院情况、住院时间延长(LOS)、总住院费用以及各种并发症。采用倾向评分匹配(PSM)来平衡RAMIE与传统MIE之间的基线特征。

结果

PSM后,分析了628例患者(加权后代表美国3140例患者)。调整后,多变量分析显示,RAMIE与传统MIE在住院死亡率(调整后的优势比[aOR]=1.45,95%置信区间[CI]:0.46-4.61)、不良出院情况(aOR = 0.76,95%CI:0.41-1.41)、住院时间延长(aOR = 0.87,95%CI:0.60-1.26)、总住院费用(aBeta = 12.23,95%CI:-19.24至43.69)或并发症(aOR = 1.05,95%CI:0.78-1.41)方面无显著差异。分层分析表明,在肥胖患者中,与MIE相比,RAMIE与总体并发症风险显著升高相关(aOR = 1.9

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf2/12104546/fc32880b332b/atcs-31-1-25-00017-figure01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf2/12104546/fc32880b332b/atcs-31-1-25-00017-figure01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf2/12104546/fc32880b332b/atcs-31-1-25-00017-figure01.jpg

相似文献

1
Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) vs. Conventional Minimally Invasive Esophagectomy (MIE) for Esophageal Cancer: A Nationwide Inpatient Sample Analysis from 2017 to 2020.机器人辅助微创食管切除术(RAMIE)与传统微创食管切除术(MIE)治疗食管癌的比较:2017年至2020年全国住院患者样本分析
Ann Thorac Cardiovasc Surg. 2025;31(1). doi: 10.5761/atcs.oa.25-00017.
2
Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: a propensity-matched analysis.机器人辅助微创食管切除术(RAMIE)与传统微创食管切除术(MIE)治疗食管癌的比较:倾向评分匹配分析。
Dis Esophagus. 2020 Apr 15;33(4). doi: 10.1093/dote/doz060.
3
Survival After Esophagectomy: A Propensity-Matched Study of Different Surgical Approaches.食管癌切除术后的生存情况:不同手术方式的倾向评分匹配研究
Ann Thorac Surg. 2017 Oct;104(4):1138-1146. doi: 10.1016/j.athoracsur.2017.04.065. Epub 2017 Jul 29.
4
Long-term outcomes of robot-assisted versus minimally invasive esophagectomy in patients with thoracic esophageal cancer: a propensity score-matched study.机器人辅助与微创食管切除术治疗胸段食管癌患者的长期疗效:倾向评分匹配研究。
World J Surg Oncol. 2024 Mar 20;22(1):80. doi: 10.1186/s12957-024-03358-w.
5
National trends in operative approach to esophagectomy: utilization rates, outcomes, and overall survival.食管癌切除术手术方式的全国趋势:利用率、结果和总生存率。
Surg Endosc. 2025 Apr;39(4):2267-2274. doi: 10.1007/s00464-025-11563-1. Epub 2025 Feb 12.
6
Change from Hybrid to Fully Minimally Invasive and Robotic Esophagectomy is Possible without Compromises.从杂交手术转变为完全微创和机器人辅助食管切除术是可行的,且不会有任何妥协。
Thorac Cardiovasc Surg. 2019 Oct;67(7):589-596. doi: 10.1055/s-0038-1670664. Epub 2018 Sep 14.
7
Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer: a propensity score matched analysis.机器人辅助微创食管癌切除术的短期疗效:倾向评分匹配分析
J Cardiothorac Surg. 2018 May 23;13(1):52. doi: 10.1186/s13019-018-0727-4.
8
Lower Incidence of Postoperative Pulmonary Complications Following Robot-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: Propensity Score-Matched Comparison to Conventional Minimally Invasive Esophagectomy.机器人辅助微创食管癌根治术治疗食管癌术后肺部并发症发生率较低:与传统微创食管癌根治术的倾向评分匹配比较。
Ann Surg Oncol. 2021 Feb;28(2):639-647. doi: 10.1245/s10434-020-09081-6. Epub 2020 Sep 5.
9
Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Meta-analysis.机器人与传统微创食管癌切除术治疗食管癌的比较:一项荟萃分析。
Ann Surg. 2023 Jul 1;278(1):39-50. doi: 10.1097/SLA.0000000000005782. Epub 2022 Dec 20.
10
Does the Approach Matter? Comparing Survival in Robotic, Minimally Invasive, and Open Esophagectomies.手术方式重要吗?比较机器人、微创和开放性食管切除术的生存情况。
Ann Thorac Surg. 2019 Feb;107(2):378-385. doi: 10.1016/j.athoracsur.2018.08.039. Epub 2018 Oct 9.

引用本文的文献

1
Surgical treatment strategy for elderly patients with esophageal cancer in the new era: a narrative review.新时代老年食管癌患者的外科治疗策略:一项叙述性综述
Surg Today. 2025 Sep 11. doi: 10.1007/s00595-025-03133-8.

本文引用的文献

1
Robot-assisted minimally invasive esophagectomy versus minimally invasive esophagectomy for thoracic lymph node dissection in patients with squamous cell carcinoma: a retrospective comparative cohort study.机器人辅助微创食管切除术与微创食管切除术治疗鳞状细胞癌患者胸段淋巴结清扫的回顾性比较队列研究
J Thorac Dis. 2024 Mar 29;16(3):2115-2124. doi: 10.21037/jtd-24-201. Epub 2024 Mar 22.
2
Advances in the Surgical Management of Esophageal Cancer.食管癌的外科治疗进展。
Hematol Oncol Clin North Am. 2024 Jun;38(3):559-568. doi: 10.1016/j.hoc.2024.03.001. Epub 2024 Apr 5.
3
Long-term outcomes of robot-assisted versus minimally invasive esophagectomy in patients with thoracic esophageal cancer: a propensity score-matched study.
机器人辅助与微创食管切除术治疗胸段食管癌患者的长期疗效:倾向评分匹配研究。
World J Surg Oncol. 2024 Mar 20;22(1):80. doi: 10.1186/s12957-024-03358-w.
4
Milestones in the History of Esophagectomy: From Torek to Minimally Invasive Approaches.食管切除术的历史里程碑:从 Torek 到微创方法。
Medicina (Kaunas). 2023 Oct 7;59(10):1786. doi: 10.3390/medicina59101786.
5
Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise.食管癌:概述、危险因素和发病率上升的原因。
Curr Gastroenterol Rep. 2023 Nov;25(11):275-279. doi: 10.1007/s11894-023-00899-0. Epub 2023 Oct 9.
6
Robotic-Assisted Esophagectomy: Current Situation and Future Perspectives.机器人辅助食管切除术:现状与未来展望。
Ann Thorac Cardiovasc Surg. 2023 Aug 20;29(4):168-176. doi: 10.5761/atcs.ra.23-00064. Epub 2023 May 23.
7
Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Meta-analysis.机器人与传统微创食管癌切除术治疗食管癌的比较:一项荟萃分析。
Ann Surg. 2023 Jul 1;278(1):39-50. doi: 10.1097/SLA.0000000000005782. Epub 2022 Dec 20.
8
Robotic Minimally Invasive Esophagectomy.机器人辅助微创食管切除术。
Thorac Surg Clin. 2023 Feb;33(1):81-88. doi: 10.1016/j.thorsurg.2022.09.004.
9
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.2020年食管鳞状细胞癌和食管腺癌发病率及死亡率的全球格局以及至2040年的预测:来自GLOBOCAN 2020的新估计
Gastroenterology. 2022 Sep;163(3):649-658.e2. doi: 10.1053/j.gastro.2022.05.054. Epub 2022 Jun 4.
10
A review on the anesthetic management of obese patients undergoing surgery.肥胖患者手术的麻醉管理综述。
BMC Anesthesiol. 2022 Apr 5;22(1):98. doi: 10.1186/s12871-022-01579-8.